Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508

Suresh S. Ramalingam,Suzanne E. Dahlberg,Chandra P. Belani,Joel N. Saltzman,Nathan A. Pennell,Gopakumar S. Nambudiri,John McCann,Jerome D. Winegarden,Mohammed A. Kassem,Mohamed K. Mohamed,Jan M. Rothman,Alan P. Lyss,Leora Horn,Thomas E. Stinchcombe,Joan H. Schiller

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508

2019

Suresh S. Ramalingam
Suzanne E. Dahlberg
Chandra P. Belani
Joel N. Saltzman
Nathan A. Pennell
Gopakumar S. Nambudiri
John McCann
Jerome D. Winegarden
Mohammed A. Kassem
Mohamed K. Mohamed
Jan M. Rothman
Alan P. Lyss
Leora Horn
Thomas E. Stinchcombe
Joan H. Schiller

PURPOSEPemetrexed or bevacizumab is used for maintenance therapy of advanced nonsquamous non–small-cell lung cancer (NSCLC). The combination of bevacizumab and pemetrexed has also demonstrated effi...

Keywords:

Pathology
Bevacizumab
Pemetrexed
Lung cancer
Cell
Oncology
Internal medicine
Maintenance therapy
Medicine
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations